Rx Medicare

Medicare News

Flower

Newly Published Clinical Data Shows Caldolor(R) (Ibuprofen) Injection Reduces Opioid Use While Improving Pain Relief In Post-Operative Patients

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

Read More…

  • Share/Bookmark

Related Posts

Tags: , , , , , , , , , , , , , , ,

Comments are closed.